Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

NOX 100

Next Previous
X
Search
Drug Profile

NOX 100

Alternative Names: Norathiol; NOX-100

Latest Information Update: 03 Oct 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Medinox
  • Developer Medinox; Orient Europharma
  • Class Free radicals; Hexanols; Small molecules; Thiocarbamates; Vascular disorder therapies
  • Mechanism of Action Nitric oxide inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Intradialytic hypotension; Septic shock
  • Discontinued Acute lung injury; Adult respiratory distress syndrome; Transplant rejection

Most Recent Events

  • 03 Oct 2019 Chemical structure information added
  • 01 Jul 2015 Medinox and Orient Europharma completes a phase II trial in Intradialytic hypotension in Taiwan (IV) (NCT01672008)
  • 08 Jun 2015 Phase-I/II clinical development is ongoing for septic shock, and phase-II development is ongoing for intradialytic hypotension

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top